• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重酒精戒断的治疗:聚焦辅助药物

Treatment of Severe Alcohol Withdrawal: A Focus on Adjunctive Agents.

作者信息

Guirguis Erenie, Richardson Jonathan, Kuhn Tara, Fahmy Ashley

机构信息

Palm Beach Atlantic University, West Palm Beach, FL, USA.

出版信息

J Pharm Technol. 2017 Oct;33(5):204-212. doi: 10.1177/8755122517714491. Epub 2017 Jun 19.

DOI:10.1177/8755122517714491
PMID:34860943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5998420/
Abstract

To review adjunctive treatment options for severe alcohol withdrawal. The search strategy included a search of Ovid MEDLINE using keywords , , , , , , , , , and and included articles dated from January 1990 to March 2017. All English-language clinical trials and case reports assessing the efficacy of adjunctive agents in severe alcohol withdrawal were evaluated. Although first-line pharmacotherapy for alcohol withdrawal continues to be benzodiazepines, literature does not clearly define adjunctive treatment options for severe alcohol withdrawal. During severe alcohol withdrawal patients may become unable to tolerate or may become unresponsive to high-dose benzodiazepines. Large doses of benzodiazepines may also result in oversedation, respiratory insufficiency, and worsening delirium. Phenobarbital and dexmedetomidine are both viable adjunctive treatment options for severe alcohol withdrawal. Current evidence has shown these agents decrease the dose requirements of benzodiazepines with limited incidence of adverse reactions. Propofol may also be a viable option in mechanically ventilated patients, but its lack of clear safety and efficacy advantages over current treatment options may limit its use in practice. Clonidine, oral anticonvulsants, and ketamine require further controlled clinical trials to clearly define their role in the treatment of severe alcohol withdrawal.

摘要

回顾严重酒精戒断的辅助治疗选择。检索策略包括使用关键词、、、、、、、、、和在Ovid MEDLINE上进行检索,检索范围包括1990年1月至2017年3月发表的文章。对所有评估辅助药物在严重酒精戒断中疗效的英文临床试验和病例报告进行了评估。虽然酒精戒断的一线药物治疗仍然是苯二氮䓬类药物,但文献并未明确界定严重酒精戒断的辅助治疗选择。在严重酒精戒断期间,患者可能无法耐受高剂量苯二氮䓬类药物或对其无反应。大剂量苯二氮䓬类药物也可能导致过度镇静、呼吸功能不全和谵妄加重。苯巴比妥和右美托咪定都是严重酒精戒断可行的辅助治疗选择。目前的证据表明,这些药物可降低苯二氮䓬类药物的剂量需求,不良反应发生率有限。丙泊酚对于机械通气患者也可能是一种可行的选择,但其相对于目前治疗选择缺乏明确的安全性和有效性优势,可能会限制其在实际中的应用。可乐定、口服抗惊厥药和氯胺酮需要进一步的对照临床试验来明确它们在严重酒精戒断治疗中的作用。

相似文献

1
Treatment of Severe Alcohol Withdrawal: A Focus on Adjunctive Agents.严重酒精戒断的治疗:聚焦辅助药物
J Pharm Technol. 2017 Oct;33(5):204-212. doi: 10.1177/8755122517714491. Epub 2017 Jun 19.
2
Treatment of Severe Alcohol Withdrawal.严重酒精戒断的治疗
Ann Pharmacother. 2016 May;50(5):389-401. doi: 10.1177/1060028016629161. Epub 2016 Feb 9.
3
The emergency medicine management of severe alcohol withdrawal.重度酒精戒断的急诊医学管理
Am J Emerg Med. 2017 Jul;35(7):1005-1011. doi: 10.1016/j.ajem.2017.02.002. Epub 2017 Feb 4.
4
Review of adjunctive dexmedetomidine in the management of severe acute alcohol withdrawal syndrome.右美托咪定辅助治疗重度急性酒精戒断综合征的综述
Am J Drug Alcohol Abuse. 2015;41(5):382-91. doi: 10.3109/00952990.2015.1058390.
5
The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.在成人重症监护病房患者中,使用右美托咪定作为基于苯二氮䓬类药物治疗的辅助药物以降低酒精戒断谵妄的严重程度:一项系统评价。
JBI Database System Rev Implement Rep. 2015 Jan;13(1):224-52. doi: 10.11124/jbisrir-2015-1602.
6
Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.评估氯胺酮辅助苯二氮䓬类药物治疗酒精戒断综合征的效果。
Ann Pharmacother. 2015 Jan;49(1):14-9. doi: 10.1177/1060028014555859. Epub 2014 Oct 16.
7
Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review protocol.右美托咪定作为酒精戒断综合征治疗的辅助疗法:一项系统评价方案
JBI Database System Rev Implement Rep. 2019 Oct;17(10):2159-2164. doi: 10.11124/JBISRIR-2017-003949.
8
Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.危重症患者急性酒精戒断综合征的管理
Pharmacotherapy. 2016 Jul;36(7):797-822. doi: 10.1002/phar.1770. Epub 2016 Jun 30.
9
Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.丙泊酚用于治疗难治性酒精戒断综合征:文献综述
Pharmacotherapy. 2016 Apr;36(4):433-42. doi: 10.1002/phar.1726. Epub 2016 Apr 1.
10
Dexmedetomidine for Alcohol Withdrawal Syndrome.右美托咪定用于酒精戒断综合征
Ann Pharmacother. 2015 Dec;49(12):1336-42. doi: 10.1177/1060028015607038. Epub 2015 Sep 23.

引用本文的文献

1
Evaluating the efficacy of valproic acid in alcohol use disorder: a systematic analysis of clinical trials from ClinicalTrials.gov.评估丙戊酸在酒精使用障碍中的疗效:来自ClinicalTrials.gov的临床试验系统分析。
Front Pharmacol. 2025 Apr 25;16:1503035. doi: 10.3389/fphar.2025.1503035. eCollection 2025.
2
Prevention of alcohol withdrawal syndrome in the surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.外科重症监护病房中酒精戒断综合征的预防:美国创伤外科协会重症监护委员会临床共识文件
Trauma Surg Acute Care Open. 2022 Nov 21;7(1):e001010. doi: 10.1136/tsaco-2022-001010. eCollection 2022.

本文引用的文献

1
Alcohol withdrawal syndrome in medical patients.内科患者的酒精戒断综合征。
Cleve Clin J Med. 2016 Jan;83(1):67-79. doi: 10.3949/ccjm.83a.14061.
2
Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study.在重症监护病房中,将右美托咪定添加到苯二氮䓬类药物用于酒精戒断综合征患者:一项随机对照研究。
Ann Intensive Care. 2015 Dec;5(1):33. doi: 10.1186/s13613-015-0075-7. Epub 2015 Nov 2.
3
Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions.对经历酒精戒断的重症患者的回顾性研究:右美托咪定与丙泊酚和/或劳拉西泮持续输注的比较
Hosp Pharm. 2015 Mar;50(3):208-13. doi: 10.1310/hpj5003-208.
4
Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol.跨医疗系统管理苯二氮䓬类药物难治性酒精戒断:使用或不使用丙泊酚的苯二氮䓬类药物剂量递增
Drug Alcohol Depend. 2015 Sep 1;154:296-9. doi: 10.1016/j.drugalcdep.2015.07.005. Epub 2015 Jul 16.
5
Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal.评估右美托咪定与丙泊酚相比作为酒精戒断患者辅助治疗的效果。
Clin Pharmacol. 2014 Oct 31;6:171-7. doi: 10.2147/CPAA.S70490. eCollection 2014.
6
Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome.评估氯胺酮辅助苯二氮䓬类药物治疗酒精戒断综合征的效果。
Ann Pharmacother. 2015 Jan;49(1):14-9. doi: 10.1177/1060028014555859. Epub 2014 Oct 16.
7
Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States.过度饮酒对美国死亡人数及潜在寿命损失年数的影响。
Prev Chronic Dis. 2014 Jun 26;11:E109. doi: 10.5888/pcd11.130293.
8
Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens.丙泊酚输注在酒精戒断所致难治性震颤谵妄中的应用。
Dan Med J. 2014 May;61(5):A4807.
9
Inpatient management of acute alcohol withdrawal syndrome.急性酒精戒断综合征的住院管理。
CNS Drugs. 2014 May;28(5):401-10. doi: 10.1007/s40263-014-0163-5.
10
Use of propofol-containing versus benzodiazepine regimens for alcohol withdrawal requiring mechanical ventilation.在需要机械通气的酒精戒断治疗中,含丙泊酚方案与苯二氮䓬类方案的应用。
Ann Pharmacother. 2014 Apr;48(4):456-61. doi: 10.1177/1060028013515846. Epub 2014 Jan 16.